A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants

NCT07229404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C

Sponsor

Bayer